| HOME >> BIOLOGY >> TECHNOLOGY |
Note:
(1) The Company has revised preliminary purchase price allocation in
connection with FISH acquisition based on revised internal valuation.
The final purchase price allocation will be determined when the
valuation by independent valuers is complete.
China Medical Technologies, Inc.
Unaudited Condensed Consolidated Statements of Income
For the Three Months Ended
June 30, March 31,
2006 2007 June 30, 2007
RMB RMB RMB US$
(in thousands except for per ADS information)
Revenues, net
(1) 90,948 163,103 151,490 19,901
Cost of
revenues (26,617) (43,766) (57,496) (7,553)
Gross profit 64,331 119,337 93,994 12,348
Operating
expenses:
Research and
development (5,861) (7,960) (9,779) (1,285)
Sales and
marketing (4,161) (5,395) (5,755) (756)
General and
Administrative (11,528) (18,259) (13,946) (1,832)
Total
operating
expenses (21,550) (31,614) (29,480) (3,873)
Operating
income 42,781 87,723 64,514 8,475
Other income -- 2,300 100 13
Interest
income 7,743 15,143 8,694 1,142
Interest
expense-
convertible
notes -- (10,183) (10,078) (1,324)
Interest
expense-
other -- -- (
'/>"/>
| SOURCE China Medical Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |